Showing results (111-120 of 126) with videos related to
Sort By:
Pageof 13
Alimentary Pharmacology & Therapeutics|April 12, 2019
Beneficial response to mycophenolate mofetil by patients with autoimmune hepatitis who have failed standard therapy, is predicted by older age and lower immunoglobulin G and INR levelsAmanda J Nicoll, Stuart K Roberts, Ricky Lim, et al.The Lancet. Haematology|December 3, 2017
Reduction of body iron in HFE-related haemochromatosis and moderate iron overload (Mi-Iron): a multicentre, participant-blinded, randomised controlled trialSim Y Ong, Lyle C Gurrin, Lara Dolling, et al.The Journal of Biological Chemistry|July 31, 2014
N-terminal domain of prion protein directs its oligomeric associationClare R Trevitt, Laszlo L P Hosszu, Mark Batchelor, et al.Hepatology (Baltimore, Md.)|June 29, 2010
HFE Cys282Tyr homozygotes with serum ferritin concentrations below 1000 microg/L are at low risk of hemochromatosisKatrina J Allen, Nadine A Bertalli, Nicholas J Osborne, et al.BMJ Open|August 14, 2015
Should HFE p.C282Y homozygotes with moderately elevated serum ferritin be treated? A randomised controlled trial comparing iron reduction with sham treatment (Mi-iron)Sim Yee Ong, Lara Dolling, Jeannette L Dixon, et al.Hepatology (Baltimore, Md.)|June 26, 2009
HFE C282Y/H63D compound heterozygotes are at low risk of hemochromatosis-related morbidityLyle C Gurrin, Nadine A Bertalli, Gregory W Dalton, et al.Science (New York, N.Y.)|August 9, 2014
C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteinsSarah Mizielinska, Sebastian Grönke, Teresa Niccoli, et al.Hepatology International|June 3, 2022
Epidemiology and outcomes of primary sclerosing cholangitis: an Australian multicentre retrospective cohort studyNatassia Tan, N Ngu, T Worland, et al.The New England Journal of Medicine|January 18, 2008
Iron-overload-related disease in HFE hereditary hemochromatosisKatrina J Allen, Lyle C Gurrin, Clare C Constantine, et al.Hepatology Communications|May 2, 2024
Surveillance MRI is associated with improved survival in patients with primary sclerosing cholangitisNatassia Tan, Natalie Ngu, Thomas Worland, et al.Pageof 13